RTI Surgical appoints Chad Croasdale as Chief Commercial Officer

Published on July 10, 2024

ALACHUA, Fla., July 10, 2024; RTI Surgical (“RTI” or “the Company”), a leading CDMO pushing the boundaries of innovation and tissue engineering to meet patient needs in regenerative medicine, announced today the appointment of Chad Croasdale as Chief Commercial Officer. Chad has more than 20 years of commercial and financial experience in the medical technology …

The post RTI Surgical appoints Chad Croasdale as Chief Commercial Officer appeared first on Ortho Spine News.